Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 152-156, March 2010

Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone

  • Orazio Caffo, M.D.

      Affiliations

    • Medical Oncology Department, Santa Chiara Hospital, Trento, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-0461-903451; fax: +39-461-903364
    • ,
  • Teodoro Sava, M.D.

      Affiliations

    • Medical Oncology Department, University of Verona, Verona, Italy
    • ,
  • Evi Comploj, M.D.

      Affiliations

    • Urology Department, San Maurizio Hospital, Bolzano, Italy
    • ,
  • Maria Anna Giampaolo, M.D.

      Affiliations

    • Oncology Department, Civil Hospital, Anagni, Italy
    • ,
  • Romana Segati, M.D.

      Affiliations

    • Oncology Department, Civil Hospital, Feltre, Italy
    • ,
  • Francesco Valduga, M.D.

      Affiliations

    • Medical Oncology Department, Santa Chiara Hospital, Trento, Italy
    • ,
  • Gianluigi Cetto, M.D.

      Affiliations

    • Medical Oncology Department, University of Verona, Verona, Italy
    • ,
  • Enzo Galligioni, M.D.

      Affiliations

    • Medical Oncology Department, Santa Chiara Hospital, Trento, Italy

Received 1 June 2008; received in revised form 28 July 2008; accepted 29 July 2008. published online 13 October 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(08)00192-0

doi:10.1016/j.urolonc.2008.07.033

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 152-156, March 2010

Article Tools